ADHD News & Research
Return to ADHD Medication Update: New Clinical Data for Dyanavel XR

ADHD Medication Update: New Clinical Data for Dyanavel XR

At a recent neuroscience conference, the manufacturer of Dyanavel XR presented four posters regarding the stimulant medication’s extended release oral suspension mechanism that suggest it takes effect within 30 minutes, lasts up to 13 hours, and helps to reduce ADHD symptoms in patients aged 6 and older.

There are no comments.

Leave a Reply